In The News
HA-BMAC yielded more durable knee cartilage repair at 5 years vs microfracture
Older patients with larger lesions or who had multiple lesions treated had better 5-year outcomes with HA-BMAC than with microfracture.
A hyaluronic acid-based scaffold with bone marrow aspirate concentrate used in patients with a chondral injury achieved better outcomes and more durable cartilage repair at medium-term follow-up than microfracture.
Anika Announces Data Presentations on HYALOFAST Hyaluronic Acid-Based Scaffold at 2016 World Congress of the International Cartilage Repair Society
Source: Anika Therapeutics
BEDFORD, Mass. & NAPLES, Italy--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today announced four data presentations on HYALOFAST, a biodegradable HA-based scaffold, at the 13th World Congress of the International Cartilage Repair Society (ICRS).